패혈증 쇼크에서 단삼 추출물의 억제 효과와 그 기전에 관한 연구
Protective Effects and Mechanisms of Salvia Miltiorrhizae Radix Extract on Endotoxin Shock
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives : This study was performed to investigate the protective effects and mechanisms of Salvia miltiorrhizae Radix extract (SME) on endotoxin shock. Methods : We used two models; LPS-induced sepsis model for in vivo model, and murine peritoneal macrophages responses for in vitro. SME was administrated orally to mice. After 1 hr, LPS was injected intraperitoneally. Survival rate was checked each time per 12 hr for 5 days. Mice were sacrificed 3 hr after LPS injection, then blood samples and organs were harvested. Cytokines secretion was measured by ELISA. Organs tissues were observed with microscope. Murine peritoneal macrophages were cultured for 1 hr either in a medium alone or in a medium that contained SME, as indicated. Then, the cells were treated with LPS for 24 hr. mRNA levels of cytokines were measured by real-time RT-PCR. Cytokine levels in the supernatants were measured by ELISA. The amount of nitrite was measured by using the Griess method to evaluate NO production. The cell lysates were analysed by Western blotting using antibodies for iNOS and β-actin was used as an internal control to monitor equal protein loading. Results : SME improverd the survival rate of mice model. SME inhibited the secretion of inflammatory cytokines and organs damages on Endotoxin Shock model. SME suppressed cytokine expression, cytokine secretion,NO production, iNOS expression in LPS-induced murine peritoneal macrophages. Conclusions : The results suggest that SME has protective effects on endotoxin shock through suppression of inflammatory cytokines, organ damages, NO production and so on.
Abstract
Objectives : This study was performed to investigate the protective effects and mechanisms of Salvia miltiorrhizae Radix extract (SME) on endotoxin shock. Methods : We used two models; LPS-induced sepsis model for in vivo model, and murine peritoneal macrophages responses for in vitro. SME was administrated orally to mice. After 1 hr, LPS was injected intraperitoneally. Survival rate was checked each time per 12 hr for 5 days. Mice were sacrificed 3 hr after LPS injection, then blood samples and organs were harvested. Cytokines secretion was measured by ELISA. Organs tissues were observed with microscope. Murine peritoneal macrophages were cultured for 1 hr either in a medium alone or in a medium that contained SME, as indicated. Then, the cells were treated with LPS for 24 hr. mRNA levels of cytokines were measured by real-time RT-PCR. Cytokine levels in the supernatants were measured by ELISA. The amount of nitrite was measured by using the Griess method to evaluate NO production. The cell lysates were analysed by Western blotting using antibodies for iNOS and β-actin was used as an internal control to monitor equal protein loading. Results : SME improverd the survival rate of mice model. SME inhibited the secretion of inflammatory cytokines and organs damages on Endotoxin Shock model. SME suppressed cytokine expression, cytokine secretion,NO production, iNOS expression in LPS-induced murine peritoneal macrophages. Conclusions : The results suggest that SME has protective effects on endotoxin shock through suppression of inflammatory cytokines, organ damages, NO production and so on.
참고문헌 (49)
- Balk RA, "Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations", Crit Care Clin, 16(2), pp.179~192 (2000)
- Bateson M, "Sepsis : contemporary issues and implications for nursing", Br J Nurs, 24(17), pp.864~866 (2015)
- Cohen J, "Sepsis : a roadmap for future research", Lancet Infect Dis, 15, pp.581~614 (2015)
- Wenzel RP, "Septic shock—evaluating another failed treatment", N Engl J Med, 366, pp.2122~2124 (2012)
- Czura CJ, ""Merinoff symposium 2010 : sepsis"—speaking with one voice", Mol Med, 17, pp.2~3 (2011)
- Vincent JL, "Sepsis definitions : time for change", Lancet, 381, pp.774~775 (2013)
- Janeway CA Jr, "Innate immune recognition", Annu Rev Immunol, 20, pp.197~216 (2002)
- Li P, "The molecular mechanism of interaction between sushi peptide and Pseudomonas endotoxin", Cell Mol Immunol, 3(1), pp.21~28 (2006)
- Beutler B, "Innate immune sensing and its roots : the story of endotoxin", Nat Rev Immunol, 3, pp.169~176 (2003)
- Textbook Compilation Committee of National University of Traditional Korean Dermatology & Surgery, "Text of Traditional Korean Dermatology & Surgery", pp.139~162 (2007), Sunwoo
- Herbology Editorial Committee of Korean Medicine schools, "Herbology", pp.419~420 (2000), Younglimsa
- Shin MK, "Clinical Traditional Herbology", pp.534~535 (2010), Younglimsa
- Kim HC, "Herbal Pharmacology", pp.332~334 (2001), Jipmundang
- Ahn DK, "Korean Herbal illustrations", pp.558~ (1998), Kyohaksa
- Fish JM, "Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome", Circulation, 113(11), pp.1393~1400 (2006)
- Zhou L, "Danshen : an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use", J Clin Pharmacol, 45(12), pp.1345~1359 (2005)
- Wing-Shing Cheung D, "The roots of Salvia miltiorrhiza(Danshen)and Pueraria lobata(Gegen)inhibit atherogenic events : a study of the combination effects of the 2-herb formula", J Ethnopharmacol, 143(3), pp.859~866 (2014)
- Tae Su Jang, "Bioassay-guided Isolation of Fatty Acid Synthase Inhibitory Diterpenoids from the Roots of Salvia miltiorrhiza Bunge", Archives of Pharmacal Research, 35(3), pp.481~486 (2012), 대한약학회
- Chen X1, "The anticancer properties of Salvia miltiorrhiza Bunge(Danshen) : a systematic review", Med Res Rev, 34(4), pp.768~794 (2014)
- Tracey KJ, "The inflammatory reflex", Nature, 420(6917), pp.853~859 (2002)
- Zedler S, "The impact of endogenous triggers on trauma-associated inflammation", Current Opinion in Critical Care, 12, pp.595~601 (2006)
- Mariathasan S, "Inflammasome adaptors and sensors : intracellular regulators of infection and inflammation", Nature Reviews Immunology, 7, pp.31~40 (2007)
- Dale DC, "The phagocytes : neutrophils and monocytes", Blood, 112(4), pp.935~945 (2008)
- Underhill DM, "Phagocytosis of microbes : complexity in action", Annu Rev Immunol, 20, pp.825~852 (2002)
- Nauseef WM, "How human neutrophils kill and degrade microbes : an integrated view", Immunol Rev, 219, pp.88~102 (2007)
- Serbina NV, "Monocyte-mediated defense against microbial pathogens", Annu Rev Immunol, 26, pp.421~452 (2008)
- Conti B, "Cytokines and fever", Front Biosci, 9, pp.1433~1449 (2004)
- Gabay C, "IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells", Clin Exp Immunol, 100(2), pp.306~313 (1995)
- Kume M, "Bacterial lipopolysaccharide decreases thrombomodulin expression in the sinusoidal endothelial cells of rats-a possible mechanism of intrasinusoidal microthrombus formation and liver dysfunction", J Hepatol, 38(1), pp.9~17 (2003)
- Surbatovic M, "Cytokine profile in severe Gram-positive and Gram-negative abdominal sepsis", Sci Rep, 5, pp.11355~ (2015)
- Hotchkiss RS, "The pathophysiology and treatment of sepsis", New Eng J Med, 348(2), pp.138~150 (2003)
- Stearns-Kurosawa DJ, "Sepsis and pathophysiology of anthrax in a nonhuman primate model", Am J Pathol, 169(2), pp.433~444 (2006)
- Wang JE, "Peptidoglycan and lipoteichoic acid in gram-positive bacterial sepsis : receptors, signal transduction, biological effects, and synergism", Shock, 20(5), pp.402~414 (2003)
- Greeneltch KM, "The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production", Brain Behav Immun, 18(5), pp.476~484 (2004)
- Grandel U, "Endothelial responses to bacterial toxins in sepsis", Crit Rev Immunol, 23(4), pp.267~299 (2003)
- Kang BC, "The Merck Manual of Diagnosis and Theraphy", pp.1226~1227 (2002), Hanwoori
- Li RQ, "Traditional Chinese Medicine Surgery", pp.95~99 (2005), China Press of Traditional Chinese Medicine
- Shang DJ, "A New Edition of Traditional Chinese Medicine Surgery", pp.81~82 (1995), Jinam Publication
- Wang P, "An complete of Traditional Chinese Medicine Surgical treatment", pp.95~100 (1997), Hebei Scientific and Techincal Publication
- Wang P, "Traditional Chinese Medicine Surgery", pp.108~112 (1994), China Press of Classics
- Chae BY, "Korean Medicine Surgery", pp.52~54 (1993), Komoonsa
- Rho SS, "Full-Color Dermatology", pp.314~318 (2006), IBC Design
- Xia YL, "The effect of Salviae militiorrhiza on TNF-α in rats with acute lung injury induced by sepsis and its protective role to lung", Pharmacology and Clinics of Chinese Materia Medica, 20(6), pp.14~16 (2004)
- Xu ZR, "Protective effect of Salvia Miltiorrhiza injection on rabbits with endotoxic shock", Chin J Emerg Med, 13(10), pp.679~684 (2004)
- Sies H, "Oxidative stress: From basic research to clinical application", Am J Med, 91(3C), pp.31S~38S (1991)
- 김희은, "Luciferase reporter gene assay를 이용한 丹蔘추출물의 소염, 진통작용에 대한 in vitro 연구", 대한한의학회지, 29(3), pp.88~99 (2008), 대한한의학회
- 이한창, "Luciferase reporter gene assay를 이용하는 丹蔘추출물의 소염 및 진통작용에 대한 in vitro 연구", 동의생리병리학회지, 18(3), pp.740~746 (2004), 한의병리학회
- 윤현정, "단삼 (Salviae Miltiorrhizae Radix) 메탄올 추출물의 항염증 효과", 대한본초학회지, 22(4), pp.65~73 (2007), 대한본초학회
- 이세은, "丹蔘 추출물의 항산화 효과에 의한 RAW264.7 cell에서의 항염증 작용", 대한본초학회지, 30(4), pp.89~94 (2015), 대한본초학회